These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30774409)

  • 21. Diagnostic accuracy of serum squamous cell carcinoma antigen and squamous cell carcinoma antigen-immunoglobulin M for hepatocellular carcinoma: A meta-analysis.
    Zhang J; Shao C; Zhou Q; Zhu Y; Zhu J; Tu C
    Mol Clin Oncol; 2015 Sep; 3(5):1165-1171. PubMed ID: 26623071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
    Caviglia GP; Abate ML; Gaia S; Petrini E; Bosco C; Olivero A; Rosso C; Ciancio A; Pellicano R; Saracco GM; Rizzetto M; Smedile A
    Panminerva Med; 2017 Dec; 59(4):283-289. PubMed ID: 28650134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical application of determining serum AFP-IgM complexes for diagnosis of small hepatocellular carcinoma.
    Jiang J; Wu C; Shen Y; Xu B; Zheng X; Li X; Xu N
    Anticancer Res; 2011 Feb; 31(2):687-91. PubMed ID: 21378357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of serum alpha fetoprotein-L3 as an accuracy novel biomarker for the early diagnosis of hepatocellular carcinoma in Egyptian patients.
    Ibrahim HM; Elghannam MZ; Elkhawaga OAY; El-Sokkary AMA
    Saudi J Biol Sci; 2021 Oct; 28(10):5760-5764. PubMed ID: 34588888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients.
    Guarino M; Di Costanzo GG; Gallotta A; Tortora R; Paneghetti L; Auriemma F; Tuccillo C; Fassina G; Caporaso N; Morisco F
    Scand J Clin Lab Invest; 2017 Oct; 77(6):448-453. PubMed ID: 28609160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
    Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
    PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-215 as a Diagnostic Marker in Egyptian Patients with Hepatocellular Carcinoma.
    El Mahdy HA; Abdelhamid IA; Amen AI; Abdelsameea E; Hassouna MM
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2723-2731. PubMed ID: 31554369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
    Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
    Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-155 and MiR-665 Role as Potential Non-invasive Biomarkers for Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    Mohamed AA; Omar AAA; El-Awady RR; Hassan SMA; Eitah WMS; Ahmed R; Khater A; Tantawi OMS; Mohamed AA
    J Transl Int Med; 2020 Mar; 8(1):32-40. PubMed ID: 32435610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
    Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H
    Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time?
    Montagnana M; Danese E; Lippi G
    Clin Chim Acta; 2015 May; 445():161-6. PubMed ID: 25840050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of liver cancer detection with simultaneous assessment of circulating levels of free alpha-fetoprotein (AFP) and AFP-IgM complexes.
    Beneduce L; Castaldi F; Marino M; Tono N; Gatta A; Pontisso P; Fassina G
    Int J Biol Markers; 2004; 19(2):155-9. PubMed ID: 15255549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
    Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ
    World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implication of miR-122, miR-483, and miR-335 Expression Levels as Potential Signatures in HCV-Related Hepatocellular Carcinoma (HCC) in Egyptian Patients.
    Elfert AY; Salem A; Abdelhamid AM; Salama A; Sourour DA; Shaker O; Keshk M
    Front Mol Biosci; 2022; 9():864839. PubMed ID: 35651814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage.
    Sun Q; Li J; Jin B; Wang T; Gu J
    Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):21-28. PubMed ID: 31053500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of serum alpha-fetoprotein-IgM immune complexes on the diagnosis of primary hepatocellular carcinoma.
    Jingting J; Changping W; Ning X; yibei Z; Jun W; Mei J; Bin X; Peter NE; Xueguan Z
    J Clin Lab Anal; 2009; 23(4):213-8. PubMed ID: 19623644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
    Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
    Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
    Yu F; Lu Z; Chen B; Dong P; Zheng J
    Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specificity of squamous cell carcinoma antigen (SCCA)-IgM detection in patients with HCV infection and rheumatoid factor seropositivity.
    Biasiolo A; Tono N; Zaninotto M; Merkel C; Fassina G; Plebani M; Gatta A; Pontisso P
    J Med Virol; 2013 Jun; 85(6):1005-8. PubMed ID: 23588726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.